Discovery of novel arylpyrazole series as potent and selective opioid receptor-like 1 (ORL1) antagonists
作者:Kensuke Kobayashi、Minaho Uchiyama、Hirokatsu Ito、Hirobumi Takahashi、Takashi Yoshizumi、Hiroki Sakoh、Yasushi Nagatomi、Masanori Asai、Hiroshi Miyazoe、Tomohiro Tsujita、Mioko Hirayama、Satoshi Ozaki、Takeshi Tani、Yasuyuki Ishii、Hisashi Ohta、Osamu Okamoto
DOI:10.1016/j.bmcl.2009.04.116
日期:2009.7
The synthesis and biological evaluation of new potent opioid receptor-like 1 antagonists are presented. A structure–activity relationship (SAR) study of arylpyrazole lead compound 1 obtained from library screening identified compound 31, (1S,3R)-N-[1-(3-chloropyridin-2-yl)-5-(5-fluoro-6-methylpyridin-3-yl)-4-methyl-1H-pyrazol-3-yl]methyl}-3-fluorocyclopentanamine, which exhibits high intrinsic potency
介绍了新型有效的阿片受体样1拮抗剂的合成和生物学评价。通过文库筛选获得的芳基吡唑铅化合物1的结构活性关系(SAR)研究确定了化合物31,(1 S,3 R)-N -[1-(3-氯吡啶-2-基)-5-(5 -氟-6-甲基吡啶基-3-基)-4-甲基-1 H-吡唑-3-基]甲基} -3-氟环戊胺,对其他阿片受体和hERG钾离子通道具有很高的内在效力和选择性。